Pharmacists News

• Metronomic Therapy Shows Promise in Breast Cancer Patients with HR+/HER2− metastatic breast cancer without previous systemic therapy were randomly assigned to receive either metronomic capecitabine plus AI or AI alone.
  Medscape Medical News, January 10, 2025
• New Health Cybersecurity Rule: What Docs Should Know A proposed federal rule would require hospitals and physicians’ groups to beef up health cybersecurity measures to protect patient privacy and prevent ransomware attacks. Some changes could be expensive, experts said.
  Medscape Medical News, January 10, 2025
• What’s the Best Approach for Sustained Weight Loss? With nutritional, pharmaceutical, and surgical options available for obesity, clinicians are being called upon to make decisions about how to best help their patients lose weight and keep it off.
  Medscape Medical News, January 10, 2025
• Are Patients On GLP-1s Getting the Right Nutrients? As GLP-1 RA use soars, experts are worried that patients may not be getting the right nutrients in their diets. How can clinicians support their patients’ nutritional needs?
  Medscape Medical News, January 10, 2025
• Long-Term Budesonide Shows Sustained Efficacy in EoE Long-term budesonide orodispersible tablets effectively maintained remission in patients with eosinophilic esophagitis and demonstrated a favorable safety profile.
  Medscape Medical News, January 10, 2025
• End-of-Life Care Talks Occur Late for Young Cancer Patients Documented palliative goals of care rarely occurred among adolescents and younger adults with cancer before the last 30 days of life.
  Medscape Medical News, January 10, 2025
• Can Glucarpidase Help Reverse Methotrexate Kidney Damage? Outcomes in methotrexate-induced kidney injury have shown improvement through treatment with the enzyme glucarpidase.
  Medscape Medical News, January 09, 2025
• SABCS 2024 Can Some Patients Safely Skip Postmastectomy Radiation? Most women with intermediate-risk breast cancer can safely skip chest wall irradiation after mastectomy and avoid the risks for chest wall pain, fibrosis, heart damage, and lung cancer.
  Medscape Medical News, January 09, 2025
• Why Aren’t More PCPs Offering Contraceptive Services? Experts say the primary care workforce is well suited to meet patients’ contraceptive needs but the numbers of primary care physicians offering prescriptions and procedures is strikingly low.
  Medscape Medical News, January 09, 2025
• KRAS Mutation Types Shape Pancreatic Cancer Outcomes Researchers assessed the association of KRAS mutations in metastatic PDAC with the clinical outcomes and responses to first-line chemotherapy regimens.
  Medscape Medical News, January 09, 2025
• Inventory System Supplier Settles Anti-Kickback Claim A specialty pharmacy company agreed to a $1.67 million settlement that it gave inventory management systems to retina specialty practices for free in exchange for drug orders.
  Medscape Medical News, January 09, 2025
• SABCS 2024 CDK 4/6 Blocker Prolongs Survival in HER2+ Breast Cancer “Incredible” results from the PATINA trial suggested a new standard of care for HER2, ER-positive metastatic breast cancer.
  Medscape Medical News, January 09, 2025
• Remimazolam-Flumazenil Combo Cuts Extubation Time in TAVI Compared with sevoflurane, a combination of remimazolam and flumazenil reduced the time to extubation in patients undergoing transcatheter aortic valve implantation by approximately 7 minutes, a study found.
  Medscape Medical News, January 09, 2025
• How Does End of Life Impact Diabetes Care? Older adults with type 2 diabetes received fewer noninsulin diabetes medications in their final year of life, but insulin use increased, especially among those who were frailer.
  Medscape Medical News, January 08, 2025
• Eli Lilly's Obesity Drug Gets Medicare Coverage for Sleep Apnea Eli Lilly's obesity drug Zepbound can now be covered by government-backed Medicare insurance plans for use in sleep apnea, broadening access to the blockbuster weight-loss...
  Reuters Health Information, January 08, 2025
• Study Identifies Risk Potential for Thousands Of Mutations Of a Cancer Gene Scientists have characterized the role of thousands of mutations in the BRCA2 cancer gene, findings that may help reassure worried patients about their cancer risk or guide...
  Reuters Health Information, January 08, 2025
• Choline Alfoscerate Has Modest Benefits on Cognition in T2D Daily treatment with 1200 mg of choline alfoscerate showed marginal improvement in cognitive function in patients with T2D and mild cognitive impairment, according to a randomized trial.
  Medscape Medical News, January 08, 2025
• Gabapentin Shows Lower Fall Risk Than Duloxetine in Elderly Older users of gabapentin demonstrated lower fall-related healthcare visits than duloxetine users.
  Medscape Medical News, January 08, 2025
• Intensive BP Control May Benefit CKD Patients in Real World Intensive blood pressure control in patients with chronic kidney disease showed cardiovascular benefits in real-world settings similar to those observed in the SPRINT.
  Medscape Medical News, January 07, 2025
• Dry January: Should Doctors Make It Year-Round? Have sobering studies on alcohol caused physicians to drink less themselves or changed the way doctors counsel patients on booze? The answer is complicated.
  Medscape Medical News, January 07, 2025